STAT Reporter Investigates Experimental MRT Fertility Treatment and the Global Fertility Industry

A STAT reporter's investigation into mitochondrial replacement therapy (MRT) reveals a global fertility industry where women are being used as "guinea pigs" for experimental treatments. MRT, which involves combining genetic material from three people to prevent mitochondrial diseases, is being marketed and performed in countries with lax regulations, raising serious ethical and safety concerns. The reporter's firsthand account details how clinics in Mexico, Ukraine, and Greece have offered MRT to desperate patients, often without long-term safety data or proper oversight. This matters because the push for profits and medical tourism may be outpacing scientific rigor, potentially putting mothers and children at risk. The investigation highlights the need for international regulatory frameworks and transparent clinical trials. As more countries consider legalizing MRT, the reporter's findings serve as a cautionary tale about the consequences of unregulated reproductive technologies.